Effects of different surface modifying agents on the cytotoxic and antimicrobial properties of ZnO nanoparticles

Zinc oxide (ZnO) nanoparticles (NPs) have received considerable attention in the medical field because of their antibacterial properties, primarily for killing and reducing the activity of numerous microorganisms. The purpose of this study was to determine whether surface-modified ZnO NPs exhibit different properties compared with unmodified ZnO. The antimicrobial and cytotoxic properties of modified ZnO NPs as well as their effects on inflammatory cytokine production were evaluated. ZnO NPs were prepared using a wet chemical method. Then, the surfaces of these NPs were modified using 3-aminopropyltriethoxysilane (APTES) and dimethyl sulfoxide (DMSO) as modifying agents via a chemical hydrolysis method. According to infrared spectroscopy analysis (FTIR), the structure of the ZnO remained unchanged after modification. Antibacterial assays demonstrated that APTES modification is more effective at inducing an antimicrobial effect against Gram-negative bacteria than against Gram-positive bacteria. Cytotoxicity studies showed that cell viability was dose-dependent; moreover, pristine and APTES-modified ZnO exhibited low cytotoxicity, whereas DMSO-modified ZnO exhibited toxicity even at a low NP concentration. An investigation of inflammatory cytokine production demonstrated that the extent of stimulation was related to the ZnO NP concentration but not to the surface modification, except for IFN-γ and IL-10, which were not detected even at high NP concentrations.

Encapsulation of Silver Nanoparticles in a Polystyrene Matrix by Miniemulsion Polymerization and Its Antimicrobial Activity

Surface-modified silver nanoparticles (NAg) were encapsulated into a polystyrene (PS) matrix by in situ miniemulsion polymerization. Silver nanoparticles were modified with 3-aminopropyltrimethoxysilane (APTMS) that acts as a coupling agent and costabilizer in the polymerization reaction. The PS-Nag nanocomposites synthesized via miniemulsion polymerization were made at two different concentrations of the initiator (0.7 and 2.5 g/L in H2O); at higher concentration of the initiator the conversion and efficiency of encapsulation increases, and the average particle size decreases. The PS-NAg composites showed excellent antimicrobial performance toward bacteria such as Escherichia coli and Staphylococcus aureus.